Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010238 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Masaru Tanaka. Beteiligte Einrichtung: Danube Neuroscience Research Laboratory, HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), T…. Hauptthemen laut MEDLINE: Precision Medicine, Biomarkers, Mental Disorders, Psychiatry. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psychiatry stands at a turning point, where molecular insights promise to revolutionize how we diagnose, monitor, and treat neuropsychiatric conditions, including Alzheimer’s, Parkinson’s, depression, dementia, and schizophrenia (SCZ), among others [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Danube Neuroscience Research Laboratory, HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Tisza Lajos krt. 113, H-6725 Szeged, Hungary.
ORCID-Profile: Masaru Tanaka
Zitieren
APA
Tanaka, M. (2025). Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010238
Vancouver
Tanaka M. Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010238
BibTeX
@article{Tanaka2025,
author = {Tanaka, Masaru},
title = {Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010238}
}
EUVIMED